Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.079 | 0.7 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |
mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.077 | 0.7 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |